Virios Therapeutics Inc. logo

VIRI

Virios Therapeutics Inc. · NASDAQ

Website

Virios Therapeutics Inc. (VIRI) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for VIRI in the last 30 days. The most recent was published Oct 15, 2024.

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.

Latest news

25 items

VIRI FAQ

8 questions
  • What does Virios Therapeutics Inc. do?
    Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.
  • What is the latest news on VIRI?
    Quantisnow has not tracked any new filings, ratings or press releases for VIRI in the last 30 days. The most recent wire item was published on October 15, 2024.
  • Where does VIRI stock trade?
    Virios Therapeutics Inc. (VIRI) is listed on NASDAQ.
  • What sector and industry is VIRI in?
    Virios Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Virios Therapeutics Inc. go public?
    Virios Therapeutics Inc. (VIRI) completed its IPO in 2020.
  • What are analysts saying about VIRI?
    Virios Therapeutics Inc. has had 1 recent analyst action on file. The most recent action was from HC Wainwright & Co.: Buy with a $12.00 price target on 2021-12-15. Recent price targets cluster around $12.00.
  • What companies are similar to VIRI?
    Notable peers in the same industry include MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories). Compare VIRI side-by-side with any of them on Quantisnow.
  • How can I track VIRI on Quantisnow?
    Quantisnow aggregates Virios Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VIRI to receive live email and push alerts on every new disclosure.